ã¡ãã£ã¢èšäº
æ°åã³ããã®æ²»çã«ã€ãã«ã¡ã¯ãã³ã¯ãäœã®å¹æããªããããšã調æ»ã§ç€ºããã
ããºãææ°ããŒã¯ 331
twitterã³ã¡ã³ã 269ä»¶äž 201ïœ269件
ãŸãŒãŒãŒãæå¥ããã人ã¯çŽæ¥Together Trialã«èšã£ãŠãã
ã€ãã«ã¡ã¯ãã³å¹æç¡ãâ
åœåãå¹æããããšèšãããŠããŠå®ã¯å¹æããªãäºãå€æããã®ã£ãŠäœäŸç®ã ããâŠã
ã€ãã«ã¡ã¯ã¯ãã³ãªãå¹æãããã®ããªâ
åœåãå¹æããããšèšãããŠããŠå®ã¯å¹æããªãäºãå€æããã®ã£ãŠäœäŸç®ã ããâŠã
ã€ãã«ã¡ã¯ã¯ãã³ãªãå¹æãããã®ããªâ
é°è¬è«è
ãåã¯ã¯ãã³æŽŸã«ç®ãã€ããããããšã§ãã€ãã«ã¡ã¯ãã³ã®æäžãè¡ã£ãå»åž«ãã¡ãå°é£ã«çŽé¢ããŠããäºå®ãæãããŠããŸã
Together Trialã«ãããã€ãã«ã¡ã¯ãã³ã®èª¿æ»ã«åå ããã®ã¯çŽ1500人ã®COVID-19æ£è
ã§ãã»ã»ã»æäžãããŸãããè©Šéšã®çµæã€ãã«ã¡ã¯ãã³ã¯ãå
šãå¹æããªãäºãããã£ãããšãã«ãºæ°ã¯èªã£ãŠã
èŠåºãã®éããâŠâŠãšããã§ãæªã ç°æ§ãªãŸã§ã«ã€ãã«ã¡ã¯ãã³æšãããŠã人ãè¿œããšããšããã³ã¹ãã©ããããšãã以åã«ã»ãŒå人ã®äž»èŠ³ã®åãåºãªãæ
å ±ã§æšããŠã人ãæ®ã©ã§ãæ£çŽèšã£ãŠãã³åŒãããã
ãªãŒã¹ãã©ãªã¢ã®ç 究è
ã2020幎ã«å
¬éããè«æã§ããæ°åã³ãããŠã€ã«ã¹(SARS-CoV-2)ã«å¯ŸããŠããçšåºŠã®æå¹æ§ã瀺ããããšå ±åãããããã§ãããããããã®ç 究ã¯äººäœã«æäžããããšãäžå¯èœãªã¬ãã«ã®æ¿åºŠã®ã€ãã«ã¡ã¯ãã³ã䜿çšãããŠããŸããã
ãããŒãŒãŒãã³ã¬ã¯çµæ§åœå
ããæ³¢çŽåŒã¶ããããªãããªïŒ
"åã¯ã¯ãã³æŽŸã®äººã
ãé°è¬è«è
ãã¡ããã€ãã«ã¡ã¯ãã³ãæ¯æãåŸãŠããŸã ... è©Šéšçµæã瀺ãããã«ã€ãã«ã¡ã¯ãã³ãCOVID-19ã®æ²»çã«ã¯å¹æããªãããšãæ¹ããŠåŒ·èª¿ããŠããŸã
ã«ã«ã§ããããããªãïŒ
èŠã¯ã€ãã«ã¡ã¯ãã³ã¯
å¹æã®æãè¬ãæäžãããšèšããã©ã»ãå¹æã«ãã
æ¬äººãå埩ãããšæã蟌ãäºã§
æ°åïŒãå¢ãäºãå¹æã£ãŠæïŒ
å¹æã®æãè¬ãæäžãããšèšããã©ã»ãå¹æã«ãã
æ¬äººãå埩ãããšæã蟌ãäºã§
æ°åïŒãå¢ãäºãå¹æã£ãŠæïŒ
å¹æã«ã€ããŠã¯åéç 究æã§å»åž«äž»å°æ²»éšãè¡ãããŠãããã軜çè
ã«ã¯ããå¹ãããšäž»åŒµããå»åž«ãããããææ°ã®ç 究ã§COVID-19ã®æ²»çã«ã¯ãäœã®å¹æããªããããšã瀺ãããã
ã¬ãã®æ€èšŒçµæãåºãã®ã§ããã€ãŒããã€ãã«ã¡ã¯ãã³ã¯å¹æãªãããããã·ã¯ãããã³ãæ»èªãåºãŠç¡æå³ãšã®äºãç§ãå«ã埮åŠãªå°è±¡ã§æ¬è³ªãããããã£ãŠãŸããã§ããããããã³ãšè§£èª¬ãããŠãŸãã
å
žåçãªããèšäº â
ãšãŠãæ°ã«ãªãããããŸã§ã®ç¶æ³ãããå
šããå¹æããªããªããŠããšã¯ããåŸãªãããã«æããã ãâŠã©ããªãã§ããããå©ççžåãªã©ã®ç¶æ³ãã ãã©ãå»ç§åŠçã«ã©ã®çšåºŠã®ç¢ºåºŠãªã®ãã
äœãä»åã®Together Trialã«ãããã€ãã«ã¡ã¯ãã³ã«é¢ããç 究çµæã¯æ£åŒãªè«æãšããŠçºè¡šããããã®ã§ã¯ãªã
åå£äœã¯ããããã·ã¯ãããã³ãææãªæ²»çå¹æã瀺ããªããšäžè«èªå°ããåç§ãã
åå£äœã¯ããããã·ã¯ãããã³ãææãªæ²»çå¹æã瀺ããªããšäžè«èªå°ããåç§ãã
ã«ããã®ããã¯ãã¹ã¿ãŒå€§åŠã®ç£ç£ã®ããšããã©ãžã«ã§å®æœãããŠãã倧èŠæš¡ãªè©Šéšã§ãCOVID-19ã«ã€ãã«ã¡ã¯ãã³ã«ã¯äœã®å¹æããªãããšã®çµæã
ããšã¯æ¥æ¬ã§ã®è©Šéšçµæãæ°ã«ãªãã
ããšã¯æ¥æ¬ã§ã®è©Šéšçµæãæ°ã«ãªãã
ãã åã«1床ã®èª¿æ»ã§çµè«ãåºãã®ã¯æ©ãããð€é°è¬è«è
ã¯ã¯ã¯ãã³å察è
ã ãã§ã¯ãªããšèšãããšãé ã«å
¥ããŠãããªããã°ãªããªãð€
ã€ãã«ã¡ã¯ãã³ãžã®æåŸ
ãåãäžããããšããç 究ã®èšäº
ã®ã¬ãžã³ã®ç¿»èš³ãå€ã ã
ã€ãã«ã¡ã¯ãã³ãã³ããã«å¹æãªã
ä»åŸãã€ãã«ã¡ã¯ãã³ãæ¯æããŠãããªãã°ãããªãæ¹å€ã«ãããããããšã¯ãé¿ããããªãã ããããšãèªããè©Šéšçµæã瀺ãããã«ã€ãã«ã¡ã¯ãã³ãCOVID-19ã®æ²»çã«ã¯å¹æããªãããšãæ¹ããŠåŒ·èª¿ããŠããŸãã
ã€ãã«ã¡ã¯ãã³ãã³ããã«å¹æãªã
ä»åŸãã€ãã«ã¡ã¯ãã³ãæ¯æããŠãããªãã°ãããªãæ¹å€ã«ãããããããšã¯ãé¿ããããªãã ããããšãèªããè©Šéšçµæã瀺ãããã«ã€ãã«ã¡ã¯ãã³ãCOVID-19ã®æ²»çã«ã¯å¹æããªãããšãæ¹ããŠåŒ·èª¿ããŠããŸãã
æäœã«ã¯ãã«ãšå
±ã«è©±é¡ã«ãªã
ã€ãã«ã¡ã¯ãã³ã®å¹æã®æãç¡ãã話é¡ã«ãªã£ãŠããã
äžè¬äººã«ã¯ããã¹ãŠãç解ããããšã¯é£ããããäžå¿ãã¹ãŠèªãã§ã¿ãäžã§ç§ã®èŠè§£ã¯å¹ææãã«è»é ãäžãããã
å¹æãç¡ããšããèšäºâ
å¹æãæããšããèšäºâ
ã€ãã«ã¡ã¯ãã³ã®å¹æã®æãç¡ãã話é¡ã«ãªã£ãŠããã
äžè¬äººã«ã¯ããã¹ãŠãç解ããããšã¯é£ããããäžå¿ãã¹ãŠèªãã§ã¿ãäžã§ç§ã®èŠè§£ã¯å¹ææãã«è»é ãäžãããã
å¹æãç¡ããšããèšäºâ
å¹æãæããšããèšäºâ
ç§ãªãã«ãããããªãŒã¹ãã©ãªã¢ãä¿¡çšããŸããã©ã...ã«ããã¯ãã...åŸãã«ããã®ããã...
âãæ£è
ã®äœé1kgããã400ãã€ã¯ãã°ã©ã ã®ã€ãã«ã¡ã¯ãã³ã1æ¥1åã3æ¥éã«ããã£ãŠæäžããããšãããã®ã«å€æŽãããŠããŸãããã®ãã¡ååã®è¢«éšè
ã«å¯ŸããŠã¯ãã©ã»ãé ãæäžããŠãããåæã®çµæãèšåºçµæã«å·®ç°ã¯ã¿ãããªãã£ãâ
æ®å¿µããããª
æ®å¿µããããª
(ÂŽã»Ïã»ïœ)ã»ã»ã»é§ç®ãã
çµè«åºãã£ãœãã
ãæ¢åã®è¬å€ã®äžã§COVID-19ã«ææãªå¹æãæã€ãã®ã¯ååšããªãããã確ãããããã®è©Šéšããã©ãžã«ã®çŽ1500人ã®COVID-19æ£è
ã«å¯ŸããŠè¡ãããããã€ãã«ã¡ã¯ãã³ã«ã€ããŠã¯ãäœã®å¹æããªããããšãå€æãããããªã
ãã«ãºæ°ãå
šãå¹æããªãããšãããã£ããã ããã§ãã
ã€ãã«ã¡ã¯ãã³ãã©ãããèšã£ãŠãé£äžãæãã§ããã飲ãã ãããå¹ããŠãã®ãŸãŸåž°ãããçãªç¹å¹è¬ãšããŠã®å¹æã¯æåããç¡ãã£ããã©ãç·©åå¹æãå
šãç¡ãã£ããšã®ããšã
ãŸããããããèšã£ãŠãèããªãé£äžã¯å¥œããªã ã飲ãŸããšããšæããã ã
ãã¬ãã§å®£äŒããã®ã¯ããããw
ãã¬ãã§å®£äŒããã®ã¯ããããw
ã€ãã«ã¡ã¯ãã³å¹æãªããåé倧ã®è©ŠéšçµæãåºãŠããŸã§ã¯äœãšãèšãããªãçŸæç¹ã§ãããç¹å¹è¬ãšããã奎ã¯è©æ¬ºåž«ã
ãã«ãºæ°ã¯ããç§ãå«ãçŸå Žã§ã€ãã«ã¡ã¯ãã³ãæäžããŠããèšåºå»ã¯ãååãããæ¹å€ã«ãããããŠããŸãããå»çåéã§åããŠãã人ã
ã¯ãèªèº«ã家æããè
è¿«ãããããåèªãå·ã€ãããããããŠããŸãã
ã€ãã«æŽŸã¢ãŠããïŒ
äœã®å¹æããªã
å°ŒåŽã®å»è
ãèžåŒµã£ãŠè©±ããŠãã€ãã«ã¡ã¯ãã³ããã©å¹æãªãããŠwwwwwwwwww
ããã©ããªãã§ããã
æ°ã¯ã©ãåè«ããã®ããïŒèšäºã«ããªã£ãŠããããã¬ãã«ãåºãŸãã£ãŠãã£ãŠæžã蟌ã¿ã¿ããã©
ãããã®äœæ°ãªããŠã©ã£ã¡ã®èšäºã§ããç¥ã£ãŠãããšãèšã£ãŠãã äœããªãã ãããã
ãããã®äœæ°ãªããŠã©ã£ã¡ã®èšäºã§ããç¥ã£ãŠãããšãèšã£ãŠãã äœããªãã ãããã
ãÏ(..)ã¡ã¢ãïŒ1幎ååŸã®çµè«ïŒèŠè§£ã®çžéïŒ
âæå¯çè«è¬ãæ°åã³ãããŠã€ã«ã¹ã®è€è£œã48æé以å ã«æ¢ãããšããç 究çµæ
â
âæå¯çè«è¬ãæ°åã³ãããŠã€ã«ã¹ã®è€è£œã48æé以å ã«æ¢ãããšããç 究çµæ
â
ãããªæ
å ±ããããŸãããã©ããªèª¿æ»ïŒ
ããããåŸæ¥ã®é¢šéªã®ç¹å¹è¬ããªããã ããæ¢åã®è¬ãå¹æããããç¡ãã ã
» æåŸ
ããŠãã®ã«æ®å¿µã ãªãáŠà¹Â° ê³ Â°áš
åã¯ã¯ãã³æŽŸãšãé°è¬è«è
ãšãã倧統é éžã®æãšäŒŒãŠãŸããã
å¹ãè¬ãèŠã€ããã°ããã§ãããã§ããäœããªãã®ïŒ
å¹ãè¬ãèŠã€ããã°ããã§ãããã§ããäœããªãã®ïŒ
ãµããïŒ
ããïŒïœïŒ
ã€ãã«ã¡ã¯ãã³ãã³
ã€ãã«ã¡ã¯ãã³ã«ãã³ãããæ²»çããå¹æã¯ãããŸããããŒïŒ ã€ãã«ã¡ã¯ãã³ãæäžããŠã¿ãŸãããããšãèšãåºãå»è
ããããèŠæ³šæïŒ
ããŸãæ¹å€ããããªããã©ãæšæ¥ã®ããã€ãå±ãã¯å¹æã®ãªãè¬ã匷調ããŠããã®ïŒ
倧åŠãç 究è
ãæŠãå
¬æ£ãæšèŠããè¬ã®é äœã«ã¯å€å°æå¿ããã«ã¿å以åã¯å¹æãã£ããããã«ã¿ã«ãªã£ãŠããã¯å¹æ倧å¹
ã«ããŠã³ãã€ã³ãã§å¹æããã£ã人ã¯ãã«ã¿ã§ã¯ãªãã£ããåæçç¶ã«ã¯å¹ææã
åŸéºçæ²»çã«ã¯70%å¹æã
çŸåããè¬å€ã§ãã«ã¿ã«å¹ææãã®ã¯çŽ10çš®ã
åŸéºçæ²»çã«ã¯70%å¹æã
çŸåããè¬å€ã§ãã«ã¿ã«å¹ææãã®ã¯çŽ10çš®ã
ãšããäºã§ããâŠ
æ¿åºãä¿¡çšã§ããªããã
å¹ããå¹ããªã
ã©ã£ã¡ãæ£ããããã£ãŠãªãããª
æ¿åºãä¿¡çšã§ããªããã
å¹ããå¹ããªã
ã©ã£ã¡ãæ£ããããã£ãŠãªãããª
æ¿åºãä¿¡çšã§ããªããã
ããïŒçºã§å€æããã®ããããã©ãããã ãã
é·å°Ÿãã€ãã ãã€ãã³ã°moreãã©ãããããããã
é·å°Ÿãã€ãã ãã€ãã³ã°moreãã©ãããããããã
â»æ®å¿µãªããçŸå®ãšéã£ããã¹ãªãŒããããŠãã
ãªãã®èšäºïŒä»æŽã©ããžèªå°ãããïŒ
ãªãã®èšäºïŒä»æŽã©ããžèªå°ãããïŒ
å®å
šã«åŠå®ãããã«ã¯åéã®æ²»éšãå«ãããå°ãä¿¡é Œã§ããããŒã¿ãåŸ
ã€å¿
èŠã¯ããã ãããã©ãå°ãªããšãçŸæç¹ã§å¹æããããšããããžãã£ããªè©±ã¯å人ã®çµéšã®ç¯çã
äœã®å¹æããªã?!
ãã¬ãæ°è å ±éããŠãŸãïŒ
***
***
ãã€ãã³ã°ãšãã€ãå±ã¯ããããæ
å ±ãæäŸããªããšãèŠèŽè
ã«èª€è§£ãäžããã®ã§ã¯ïŒ
ãããªèšäºããã£ãŠããããããããªãã®ã§ããâŠ
Pocket New item archived:
ã€ãã«ã¯ã¯ãã³å¹æãªãã£ãæš¡æ§
ããããã£ã€ããŠããã
ããããã ãã ã£ãŠãããããŠã€ã«ã¹ãªããã ããã
ãããããããðã®äžã®æ¯ã«å«ãŸããŠããã¹ãã€ã¯ã¿ã³ãã¯è³ªã®æŽ»åãæå¶ããè¬ã§ã
ãããããããðã®äžã®æ¯ã«å«ãŸããŠããã¹ãã€ã¯ã¿ã³ãã¯è³ªã®æŽ»åãæå¶ããè¬ã§ã
ãããªããšæžããŠãèšäºãããŸããã©ããªãã§ããã
åéç 究æã§æ²»éšäžããŠã€ã«ã¹ãæžå°ãããå¹æããããšãããŠããèªå¯ãã¹ãã ãšäž»åŒµããå»åž«ãå€ãããã ãèªå®
åŸ
æ©äžã«éçåããã±ãŒã¹ãå€ãã®ã§ãããé²æ¢ãã決ãæãšãèšãããã
ãã®å ±éãGIGAZINEãããšã¯ïŒç¬
ã«ããã®ããã¯ãã¹ã¿ãŒå€§åŠã«ããç£ç£ã®ããšããã©ãžã«ã§å€§èŠæš¡ãªæ²»éšãå®æœ
çµè«âå¹æãªã
ãã©ã»ã(æã蟌ã¿)å¹æããæåŸ ã§ããªãããã
æ¥æ¬ã§è¡ãããŠããæ²»éšãã©ãåºãã
çµè«âå¹æãªã
ãã©ã»ã(æã蟌ã¿)å¹æããæåŸ ã§ããªãããã
æ¥æ¬ã§è¡ãããŠããæ²»éšãã©ãåºãã
è«æãã®ãã®ãããªããŠè¶
èš³ïŒèª¹è¬äžå·èšäºæã£ãŠãããšãããå®ã«GIGAZINEãããã
ãªããšãªããå¹æããããããããå¹æããªããã®æ¹ãææ矩ãªæ°ããããïŒã»Ãã»ïŒ
åã¯ã¯ãã³æŽŸãCOVID-19ã®æ²»çè¬ãšããŠæšå¥šããŠããã²ãšã€ããã€ãã«ã¡ã¯ãã³ããå¹æã«ã€ããŠã¯åéç 究æã§å»åž«äž»å°æ²»éšãè¡ãããŠãããææ°ã®ç 究ã§COVID-19ã®æ²»çã«ã¯ãäœã®å¹æããªããããšã瀺ãããŸãã
ã€ãã«ã¡ã¯ã¯ãã³ãã¡ã ã£ããïŒïŒ
ä»æ¹ãªãè©ŠéšããããŸãããšèšããã°ããã®æããããªå
容ã ãªã察象ãå®ããã«å¹
åºãæäžããŠäžäœäœã®ææãåŸãããïŒäœãæ¯èŒã§ããïŒ
åã¯ã¯ãã³(ã€ãã«ã¡ã¯ãã³æŽŸ)æ»äº¡ã®ãç¥ãã
å㞠次ãž